PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Receivables - Net (2011 - 2025)

Updated

PharmaCyte Biotech (PMCB) recorded Receivables - Net of $3.36 million in fiscal Q3 2025 (quarter ended Jan 31, 2025).

Analysis

PharmaCyte Biotech (PMCB) Receivables - Net (2011 - 2025) Analysis & Trends

At the end of FY2024 (ended Apr 30, 2024), PharmaCyte Biotech reported Receivables - Net of $2.76 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 3.36 Mn
Apr 30, 2024 2.76 Mn
Apr 30, 2012 2,581.00
Jan 31, 2012 19,579.00
Oct 31, 2011 8,962.00
Jul 31, 2011 8,607.00
Apr 30, 2011 2,316.00
API Access

PharmaCyte Biotech Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=PMCB&period=max&api_key=YOUR_API_KEY